Biomarkers study on the treatment and disease pathogenesis of Vitiligo
- Conditions
- Health Condition 1: L80- Vitiligo
- Registration Number
- CTRI/2023/07/055204
- Lead Sponsor
- Central Council for research in Unani Medicine Ministry of AYUSH Govt of India
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients with clinically diagnosed vitiligo and healthy controls with matched temperament.
2.Age: 20-50 years.
3.With any duration of the disease, site, extension and distribution of the lesions.
4.Willingness to give written informed consent form.
1.Subjects with active vitiligo treatment with other drug /systems.
2.History of drug or alcoholic abuse, chronic smokers not willing to abstain from smoking during the study period.
3.Any clinically significant abnormality identified on physical examination/laboratory tests.
4.Subjects having any systemic disease and other skin diseases.
5.Subjects with known allergies, Impaired cardiac, hepatic and renal function. History of malignancy. Concomitant use of any other antioxidants.
6.Pregnant and other lactating women.
7.Participant with dermatomal Lip-Tip, genital and mucosal vitiligo and vitiligo with leukotrichia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The research would shed light on identifying potential biomarkers for early diagnosis of Vitiligo. <br/ ><br> <br/ ><br>Timepoint: 3 years
- Secondary Outcome Measures
Name Time Method The study will assist in a better comprehension of the vitiligo pathogenesis & its treatment with respect to Unani PhilosophyTimepoint: 3 years